Targeted drug therapy in non-small cell lung cancer: Clinical significance and possible solutions-Part I

靶向治疗 间变性淋巴瘤激酶 医学 肺癌 免疫疗法 表皮生长因子受体 肿瘤科 癌症 癌症研究 免疫学 内科学 恶性胸腔积液
作者
Archana Upadhya,Khushwant S. Yadav,Ambikanandan R. Misra
出处
期刊:Expert Opinion on Drug Delivery [Taylor & Francis]
卷期号:18 (1): 73-102 被引量:37
标识
DOI:10.1080/17425247.2021.1825377
摘要

INTRODUCTION: Non-small cell lung cancer (NSCLC) comprises of 84% of all lung cancer cases. The treatment options for NSCLC at advanced stages are chemotherapy and radiotherapy. Chemotherapy involves conventional nonspecific chemotherapeutics, and targeted-protein/receptor-specific small molecule inhibitors. Biologically targeted therapies such as an antibody-based immunotherapy have been approved in combination with conventional therapeutics. Approved targeted chemotherapy is directed against the kinase domains of mutated cellular receptors such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinases (ALK), neurotrophic receptor kinases (NTRK) and against downstream signaling molecules such as BRAF (v-raf murine sarcoma viral oncogene homolog B1). Approved biologically targeted therapy involves the use of anti-angiogenesis antibodies and antibodies against immune checkpoints. AREAS COVERED: The rationale for the employment of targeted therapeutics and the resistance that may develop to therapy are discussed. Novel targeted therapeutics in clinical trials are also included. EXPERT OPINION: Molecular and histological profiling of a given tumor specimen to determine the aberrant onco-driver is a must before deciding a targeted therapeutic regimen for the patient. Periodic monitoring of the patients response to a given therapeutic regimen is also mandatory so that any semblance of resistance to therapy can be deciphered and the regimen may be accordingly altered.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
AAA建材王哥完成签到,获得积分10
刚刚
刚刚
大个的应助被123采纳,获得10
1秒前
1秒前
1秒前
哈47发布了新的文献求助10
1秒前
领导范儿的应助被ZZ采纳,获得10
1秒前
Gaara0504发布了新的文献求助10
1秒前
Ava的应助被石愚志采纳,获得10
2秒前
emy发布了新的文献求助10
2秒前
受伤雨南完成签到,获得积分10
2秒前
酷波er的应助被石愚志采纳,获得10
2秒前
Lisheng000发布了新的文献求助10
2秒前
田浩阳发布了新的文献求助10
2秒前
3秒前
今后的应助被xiang采纳,获得20
3秒前
KP完成签到,获得积分10
3秒前
aaaaa发布了新的文献求助10
3秒前
我是老大的应助被Rony采纳,获得10
3秒前
dildil发布了新的文献求助10
4秒前
4秒前
Ava的应助被Chelseacyh采纳,获得10
5秒前
5秒前
5秒前
6秒前
6秒前
dd完成签到,获得积分10
7秒前
Dc完成签到,获得积分10
7秒前
李健的应助被小马采纳,获得10
7秒前
JackieLiu的应助被默默惜霜采纳,获得10
7秒前
科研通AI6.2的应助被默默惜霜采纳,获得10
7秒前
ephemeral发布了新的文献求助10
7秒前
元吉的应助被默默惜霜采纳,获得10
7秒前
秋风的应助被默默惜霜采纳,获得10
8秒前
8秒前
小蘑菇的应助被勤恳的小甜瓜采纳,获得10
8秒前
8秒前
8秒前
自己完成签到,获得积分10
9秒前
科研小趴菜完成签到,获得积分10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148